Clinical Trials Sponsored by Jiangsu Province Nanjing Brain Hospital

Total 348 results

Jiangsu HengRui Medicine Co., Ltd.
NanJing PLA 81 Hospital

Completed

Study of Apatinib After Systemic Therapy in Patients With Hepatocellular Carcinoma(AHELP)

Carcinoma, Hepatocellular

China
Dongzhimen Hospital, Beijing
Affiliated Hospital of Nantong University; Affiliated Hospital of Chengde Medical... and other collaborators

Recruiting

Analysing the Effects of Xingnaojing for Mild-to-severe Acute Ischemic Stroke

Ischemic Stroke | Acute Stroke

China
Xinhua Hospital, Shanghai Jiao Tong University...
Xin Hua Hospital of Zhejiang Province; Huai'an First People's Hospital; Nanjing... and other collaborators

Unknown

Double Randomized and Placebo Controlled Trail of Tianqi Pingchan Granule to Prevent Levodopa-Induced Dyskinesia

Levodopa-Induced Dyskinesia

China
Northern Jiangsu Province People's Hospital
Centers for Disease Control and Prevention

Recruiting

Effects of Lead Exposure on Ferroptosis Pathway

Neurotoxicity | Lead Poisoning

China
Jiangsu Province Centers for Disease Control and...
West China Hospital

Completed

Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)

COVID-19

China
Jiangsu Province Centers for Disease Control and...
West China Hospital

Withdrawn

Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells)

COVID-19

China
Peking University People's Hospital
Peking University First Hospital; Jiangsu Province Geriatric Institute

Recruiting

The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes

Diabetes Mellitus, Type 2 | Severe Insulin Deficient Diabetes

China
The First Affiliated Hospital with Nanjing Medical...
Jiangsu Province Hospital of Traditional Chinese Medicine; Xuzhou Medical University and other collaborators

Unknown

Incidence of Pulmonary Embolism During Temporary Pacing Via Femoral Versus Subclavian Vein

Pulmonary Embolism
Jiangsu Province Centers for Disease Control and...
West China Hospital

Completed

A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells)

COVID-19

China
Jiangxi University of Traditional Chinese Medicine
Nangang community healthcare center (Nanchang city, Jiangxi province, China) and other collaborators

Active, not recruiting

Heat-sensitive Moxibustion Self-administration in Patients in the Community With Primary Hypertension: Protocol for a Multi-center, Pragmatic, Non-randomized Trial

Primary Hypertension

China
The First Affiliated Hospital with Nanjing Medical...
Second Affiliated Hospital of Nantong University; Jiangsu Taizhou People's...

Recruiting

Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion

Atrial Fibrillation | Left Atrial Appendage Occlusion | Silent Cerebral Embolism

China
Jinling Hospital, China
Wenzhou Medical University; Jiangsu Province Hospital of Traditional Chinese... and other collaborators

Unknown

AR-inhibitor Bicalutamide in Treating Patients With TNBC (Arbre)

Breast Neoplasms
Jiangsu Renocell Biotech Company
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical...

Recruiting

RY_SW01 Cell Injection Therapy in Systemic Sclerosis

Systemic Sclerosis

China
Jiangsu Renocell Biotech Company
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical...

Recruiting

RY_SW01 Cell Injection Therapy in Active Lupus Nephritis

Lupus Nephritis

China
JIANG LONGWEI
Nanjing University

Recruiting

A Study of Tumor Neoantigen-specific T Cells in the Treatment of Advanced Solid Tumors (Neoantigen-T)

Tumor, Solid

China
Buhai Wang
Innovent Biologics (Suzhou) Co. Ltd.

Unknown

Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer

Cervical Cancer | Uterine Cervical Neoplasms | Cervix Cancer | Cervical Neoplasms

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer

Prostate Cancer | Biochemical Recurrence

China
The First Affiliated Hospital with Nanjing Medical...
Jiangbin Hospital Affiliated to Jiangsu University; Nanjing Second Hospital; Jiangning...

Recruiting

Clinical Study of Azacitidine Combined With Ruxolitinib in the Treatment of Higher-risk MDS/MPN

MDS/MPN

China
Sun Yat-sen University
Wuhan University; Tongji Hospital; Hunan Province Tumor Hospital; Second Affiliated... and other collaborators

Recruiting

Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma (IMRT)

Nasopharyngeal Carcinoma

China
Jiangsu Cancer Institute & Hospital
Zhongda Hospital; Central South University; Nanjing Chest Hospital; The Affiliated...

Not yet recruiting

Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia

COVID-19 Pneumonia
Shanghai Mental Health Center
Yunnan Institute For Drug Abuse; Wuxi Mental Health Center, Jiangsu Provence... and other collaborators

Completed

Transcranial Magnetic Stimulation for Treatment of Methamphetamine Dependence

Methamphetamine-dependence

China
Henan University of Traditional Chinese Medicine
Jiangsu Province Hospital of Traditional Chinese Medicine

Unknown

Bufei Jianpi Granule for Delaying Pulmonary Function Decline in Early-Stage COPD

Chronic Obstructive Pulmonary Disease

China
Shanghai Jiao Tong University School of Medicine
Guangzhou Psychiatric Hospital; Suzhou Psychiatric Hospital; Tianjin Anding Hospital and other collaborators

Recruiting

Repetitive Transcranial Magnetic Stimulation in Early Psychosis and The Functional Connectivity Biotypes

Schizophrenia; Psychosis | Clinical High Risk | First Episode Psychosis

China
Shanghai University of Traditional Chinese Medicine
Jiangsu Province Hospital of Traditional Chinese Medicine; RenJi Hospital

Completed

The Effect of Traditional Chinese Treatment Combined Adjuvant Chemotherapy in IIIb and IIIc Gastric Cancer (CHANGE)

Gastric Cancer Stage IIIB | Gastric Cancer Stage IIIC

China
Nanjing NingQi Medicine Science and Technology...
Jiangsu Cancer Institute & Hospital

Unknown

Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study

Peripheral T-cell Lymphomas

China
JIANG Qing

Completed

Prophylactic Anticoagulation for Preventing Deep Vein Thrombosis After Total Hip Arthroplasty

Deep Vein Thrombosis

China
Nanjing NingQi Medicine Science and Technology...
The First Affiliated Hospital with Nanjing Medical University; Fudan University and other collaborators

Unknown

Yiqi Wenjing Prescriptions Preventive Efficacy of Oxaliplatin-induced Peripheral Neuropathy Clinical Trial (YWPPEOPNCT)

Colorectal Cancer | Chemotherapy-induced Peripheral Neuropathy
Shanghai Zhongshan Hospital
RenJi Hospital; Eastern Hepatobiliary Surgery Hospital; Anhui Provincial Hospital and other collaborators

Unknown

Effect of Enhanced Recovery After Surgery(ERAS) After Liver Resection for Primary Liver Cancer

Carcinoma, Hepatocellular

China
Zhejiang Cancer Hospital
307 Hospital of PLA; Fudan University; Hangzhou Cancer Hospital; Zhejiang University and other collaborators

Unknown

A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)

Breast Cancer

China
The First Affiliated Hospital with Nanjing Medical...
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Neoadjuvant Study With Pyrotinib and Trastuzumab and Abraxane in Patients With HER2-enriched Breast Cancer

Breast Cancer

China
The First Affiliated Hospital with Nanjing Medical...
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma

Hepatocellular Carcinoma | Immunotherapy | Preoperative

China
The First Affiliated Hospital with Nanjing Medical...
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

Neoadjuvant Therapy of HAIC（GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

Intrahepatic Cholangiocarcinoma

China
The First Affiliated Hospital with Nanjing Medical...
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Active, not recruiting

Pemetrexed and TAS-102 in Combination With Bevacizumab in Refractory Colorectal Cancer

Colorectal Neoplasms

China
The First Affiliated Hospital with Nanjing Medical...
Jiangsu HengRui Medicine Co., Ltd.

Completed

SHR-1210 in Combination With GEMOX in Patients With Advanced BTC

Cholangiocarcinoma | Biliary Tract Cancer

China
Shenzhen Beike Bio-Technology Co., Ltd.
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical... and other collaborators

Unknown

Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Hereditary Ataxia

Hereditary Ataxia

China
Shenzhen Beike Bio-Technology Co., Ltd.
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical... and other collaborators

Unknown

Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica

Progressive Multiple Sclerosis | Neuromyelitis Optica.

China
EVIVE Biotechnology
Zhejiang Cancer Hospital; Fudan University; RenJi Hospital; Henan Cancer Hospital; Tongji Hospital and other collaborators

Completed

A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.

Neutropenia

China
The First Affiliated Hospital with Nanjing Medical...
University of Oklahoma; The Affiliated Hospital of Xuzhou Medical University; The First People's Hospital of Changzhou and other collaborators

Recruiting

LLTS to Treat Premature Ventricular Contractions (TREAT-PVC)

Premature Ventricular Contraction

China
The First Affiliated Hospital with Nanjing Medical...
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Neoadjuvant Fluzoparib in Germline BRCA-mutated Three-negative Breast Cancer Breast Cancer

TNBC - Triple-Negative Breast Cancer

China
The First Affiliated Hospital with Nanjing Medical...
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Pyrotinib in Women With High-risk in Early Stage Breast Cancer

HER2-positive Breast Cancer

China
The First Affiliated Hospital with Nanjing Medical...
Jiangsu HengRui Medicine Co., Ltd.

Completed

Microwave Ablation Combined With Camrelizumab in the Treatment of Early Breast Cancer

Breast Cancer

China
The First Affiliated Hospital with Nanjing Medical...
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Unknown

SHR-1210 Combined With Apatinib Mesylate in the Perioperative Treatment of Hepatocellular Carcinoma (HCC-009)

Hepatocellular Carcinoma

China
Beijing Health Guard Biotechnology, Inc
National Institutes for Food and Drug Control, China; Jiangsu Province Centers... and other collaborators

Completed

A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine

Human Papilloma Virus Infection

China
Nanfang Hospital of Southern Medical University
Jiangsu Simcere Pharmaceutical Co., Ltd.

Not yet recruiting

Iguratimod Combined With Tofacitinib in the Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis
PengYa
Northern Jiangsu Province People's Hospital; The Affiliated Hospital of Xuzhou... and other collaborators

Not yet recruiting

A Retrospective Study of Reco Thrombectomy Stent for Intravascular Treatment of Acute Ischemic Stroke

Neurology | Interventional Therapy

China
The First Affiliated Hospital with Nanjing Medical...
Jiangsu HanSoh Tharmaceutical Group Co., Ltd

Withdrawn

Pemetrexed and S-1 in Combination With Bevacizumab in Refractory Colorectal Cancer

Colorectal Neoplasms

China
The Second Hospital of Nanjing Medical University
Jiangsu Yuyue medical equipment & supply Co., Ltd.

Completed

Clinical Trial of YuWell YE900 Electronic Sphygmomanometer

Blood Pressure

China
Jiang Ziyan

Not yet recruiting

"Mantou" Screening for GDM Before 20 Weeks of Gestation

GDM

China
Nanfang Hospital of Southern Medical University
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients (PANORAMA)

Chemotherapy | Immunotherapy

China
Nanfang Hospital of Southern Medical University
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Carelizumab Combined With Regorafenib in the Treatment of HCC（CARE-2020）

Hepatocellular Carcinoma

China

Clinical Trials Sponsored by Jiangsu Province Nanjing Brain Hospital

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations